Ticker Details
Array Technologies, Inc. Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
IPO Date:	October 15, 2020
Sector:	Technology
Industry:	Solar
Market Cap:	$993.72M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.55 | 3.69%
Avg Daily Range (30 D):	$0.32 | 3.89%
Avg Daily Range (90 D):	$0.27 | 3.45%

Institutional Daily Volume
Avg Daily Volume:	4.51M
Avg Daily Volume (30 D):	5.46M
Avg Daily Volume (90 D):	4.79M

Trade Size
Avg Trade Size (Sh.):	123
Avg Trade Size (Sh.) (30 D):	126
Avg Trade Size (Sh.) (90 D):	122

Institutional Trades
Total Institutional Trades:	6,571
Avg Institutional Trade:	$2.34M
Avg Institutional Trade (30 D):	$2.9M
Avg Institutional Trade (90 D):	$3M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$5.09M
Avg Closing Trade (30 D):	$5.82M
Avg Closing Trade (90 D):	$5.92M
Avg Closing Volume:	397.82K

News

Jun 29, 2026 @ 7:30 AM Solar PV Mounting Systems Market Size to Hit USD 7... Source: Sns Insider

Jun 10, 2026 @ 8:44 PM Tom Lee's Small-Cap Granny Shots ETF Reloads: Firs... Source: Chandrima Sanyal

Feb 10, 2026 @ 3:00 PM Array Acquires Chimney to Expand Digital Financial... Source: Not Specified

Jan 20, 2026 @ 10:10 PM 3 Bold Predictions to Start 2026 Source: Motley Fool Staff

Jan 13, 2026 @ 7:02 PM Where Will Nextpower (NXT) Stock Be in 1 Year? Source: Leo Sun

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.83	$-.09	$-1.05
Diluted EPS	$-.83	$-.09	$-1.05
Revenue	$1.21B	$223.41M	$226.04M
Gross Profit	$285.13M	$63M	$19.33M
Net Income / Loss	$-66.98M	$2M	$-145.75M
Operating Income / Loss	$-49.17M	$7.11M	$-148.11M
Cost of Revenue	$920.06M	$160.41M	$206.71M
Net Cash Flow	$-147.5M	$-43.99M	$22.88M
PE Ratio